Evidence map›Paper›PMID 34651637›Full record

ArticleLab on a chip2021

A microfluidic platform enables comprehensive gene expression profiling of mouse retinal stem cells.

Brenda L K Coles, Mahmoud Labib, Mahla Poudineh, Brendan T Innes, Justin Belair-Hickey, Surath Gomis, Zongjie Wang, Gary D Bader, Edward H Sargent, Shana O Kelley and 1 more

Open access · greenAbstract read
In one paragraph

Article in Lab on a chip, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Measuring cell deformation by microfluidics.Frontiers in bioengineering and biotechnology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Brenda L K ColesDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.ORCID 0000-0002-1679-4605
Mahmoud LabibDepartment of Pharmaceutical Sciences, University of Toronto, Toronto, ON M5S 3M2, Canada. shana.kelley@utoronto.ca.ORCID 0000-0003-4565-2056
Mahla PoudinehDepartment of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 1A8, Canada. ted.sargent@utoronto.ca.
Brendan T InnesDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.ORCID 0000-0003-2496-3154
Justin Belair-HickeyDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.
Surath GomisDepartment of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 1A8, Canada. ted.sargent@utoronto.ca.
Zongjie WangDepartment of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 1A8, Canada. ted.sargent@utoronto.ca.ORCID 0000-0001-9900-7197
Gary D BaderDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.ORCID 0000-0003-0185-8861
Edward H SargentDepartment of Electrical & Computer Engineering, University of Toronto, Toronto, ON M5S 1A8, Canada. ted.sargent@utoronto.ca.
Shana O KelleyDepartment of Pharmaceutical Sciences, University of Toronto, Toronto, ON M5S 3M2, Canada. shana.kelley@utoronto.ca.ORCID 0000-0003-3360-5359
Derek van der KooyDepartment of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON M5S 1A8, Canada. derek.van.der.kooy@utoronto.ca.
University of Toronto · CA

Funding

Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysisR33CA204574 · NCI · UNIVERSITY OF TORONTO · PI KELLEY, SHANA O · 2017 to 2019
$824k
NCI NIH HHS R33 CA204574
6 · The paper itself

Abstract

Loss of photoreceptors due to retinal degeneration is a major cause of untreatable visual impairment and blindness. Cell replacement therapy, using retinal stem cell (RSC)-derived photoreceptors, holds promise for reconstituting damaged cell populations in the retina. One major obstacle preventing translation to the clinic is the lack of validated markers or strategies to prospectively identify these rare cells in the retina and subsequently enrich them. Here, we introduce a microfluidic platform that combines nickel micromagnets, herringbone structures, and a design enabling varying flow velocities among three compartments to facilitate a highly efficient enrichment of RSCs. In addition, we developed an affinity enrichment strategy based on cell-surface markers that was utilized to isolate RSCs from the adult ciliary epithelium. We showed that targeting a panel of three cell surface markers simultaneously facilitates the enrichment of RSCs to 1 : 3 relative to unsorted cells. Combining the microfluidic platform with single-cell whole-transcriptome profiling, we successfully identified four differentially expressed cell surface markers that can be targeted simultaneously to yield an unprecedented 1 : 2 enrichment of RSCs relative to unsorted cells. We also identified transcription factors (TFs) that play functional roles in maintenance, quiescence, and proliferation of RSCs. This level of analysis for the first time identified a spectrum of molecular and functional properties of RSCs.

Indexed as

MicrofluidicsRetinaAnimalsCell DifferentiationCell ProliferationGene Expression ProfilingMiceStem Cells

Identifiers

PMID34651637
PMCPMC8578462
OpenAlexW3206705328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.